Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Clinical trial NCT06784167 · RECRUITING
Trial details
- NCT number
- NCT06784167
- Sponsor
- OHSU Knight Cancer Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-10
- Primary completion
- 2027-01-11
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.